Stearic Acid

Stearic Acid

SCHEMBL900922

CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].CCCC[Sn+2]CCCC

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.60
CA1 P00915 1/20 0.58
CES2 O00748 4/20 0.54
CES1 P23141 4/20 0.54
NFKB1 P19838 1/20 0.48
GPR84 Q9NQS5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Behenic Acid SCHEMBL28815262 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Dodecanoate SCHEMBL29785432 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Myristic Acid SCHEMBL9245302 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Heptanoate SCHEMBL8361326 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Dodecanoate SCHEMBL4869587 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Tridecanoate SCHEMBL5459906 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Palmitic Acid SCHEMBL2452648 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Dodecanoate SCHEMBL35315 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Nonanoate SCHEMBL8365974 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1
Dodecanoate SCHEMBL27565199 1.00 FABP3 (0.60) FABP3CA1CES2CES1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240374518-A1 AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2024-11-14 US claimed
CN-118930993-A Light-colored antistatic solid tire and preparation method thereof 荣成荣鹰橡胶制品有限公司 2024-11-12 CN claimed
EP-4376889-A2 AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS Agency for Science, Technology and Research (SG) 2024-06-05 EP claimed
CN-117229726-B High-performance double-layer-structured acrylic OCA optical adhesive and preparation method thereof 深圳市高仁电子新材料有限公司 2024-05-14 CN claimed
CN-117985754-A Synthesis method of magnesium aluminum tin hydrotalcite for PVC heat stabilizer 新乡学院 2024-05-07 CN claimed
CN-117651549-A Anti-angiogenic agents and related methods 新加坡科技研究局 2024-03-05 CN claimed
US-20240043689-A1 SEALANT COMPOSITION DOW SILICONES CORPORATION 2024-02-08 US claimed
CN-117229726-A High-performance double-layer-structured acrylic OCA optical adhesive and preparation method thereof 深圳市高仁电子新材料有限公司 2023-12-15 CN claimed
EP-4267677-A1 SEALANT COMPOSITION Dow Silicones Corporation (US) 2023-11-01 EP claimed
CN-116457410-A Sealant composition 美国陶氏有机硅公司 2023-07-18 CN claimed
WO-2023009066-A2 AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-02-02 WO claimed
WO-2022140217-A1 SEALANT COMPOSITION DOW SILICONES CORPORATION (US) 2022-06-30 WO claimed
CN-109476811-B One-part low temperature cure coating formed via a dual layer cure mechanism 巴斯夫涂料有限公司 2022-02-11 CN claimed
EP-0761733-B1 Rubber compositions and pneumatic tires using the same BRIDGESTONE CORP (JP) 2007-05-09 EP claimed
EP-0685460-B1 PROCESS FOR PRODUCING HIGHER CYANOACETIC ESTER MITSUBISHI RAYON CO (JP) 1999-06-09 EP claimed
US-5714570-A CATALYSTS CONTAINS ANTIMONY COMPOUND, TITANIUM COMPOUND AND TIN COMPOUND KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1998-02-03 US claimed
EP-0221877-B1 PRIMER COATINGS FINA RESEARCH S.A. (BE) 1992-04-01 EP claimed
JP-60006740-A None JP disclosed
US-4085077-A HEAT DISCOLORATION RESISTANCE M&T CHEMICALS INC. (US) 1978-04-18 US disclosed
US-4036819-A FROM CHLORINATED AROMATIC DICARBOXYLIC ACID DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1977-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240374518-A1 AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS VEGFA, PGF, FLT4 FABP3 168/4885CA1 1756/4885CES2 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.